A detailed history of High Tower Advisors, LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 37,914 shares of DNLI stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,914
Previous 39,220 3.33%
Holding current value
$1.12 Million
Previous $804,000 9.45%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$14.96 - $23.22 $19,537 - $30,325
-1,306 Reduced 3.33%
37,914 $880,000
Q1 2024

May 06, 2024

SELL
$15.83 - $23.35 $6,537 - $9,643
-413 Reduced 1.04%
39,220 $804,000
Q4 2023

Feb 12, 2024

SELL
$16.2 - $23.18 $238,123 - $340,722
-14,699 Reduced 27.05%
39,633 $850,000
Q3 2023

Nov 08, 2023

SELL
$20.63 - $30.17 $3,816 - $5,581
-185 Reduced 0.34%
54,332 $1.12 Million
Q2 2023

Aug 14, 2023

BUY
$23.37 - $32.96 $65,739 - $92,716
2,813 Added 5.44%
54,517 $1.61 Million
Q1 2023

May 11, 2023

BUY
$21.91 - $32.67 $646,235 - $963,601
29,495 Added 132.81%
51,704 $1.19 Million
Q4 2022

Feb 08, 2023

BUY
$26.28 - $33.92 $88,984 - $114,853
3,386 Added 17.99%
22,209 $617,000
Q3 2022

Nov 09, 2022

BUY
$25.97 - $38.53 $488,833 - $725,250
18,823 New
18,823 $573,000

Others Institutions Holding DNLI

About Denali Therapeutics Inc.


  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.96B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.